معرفی
Suzanah Boyd is a Researcher at the Macquarie Medical School, part of the Faculty of Medicine, Health and Human Sciences at Macquarie University. She holds a Doctor of Philosophy (PhD) and focuses on melanoma research, molecular oncology, and biomarker development. Her work spans understanding cancer genetics, treatment resistance mechanisms, and the application of circulating tumor DNA in clinical diagnostics.
Research Interests: Dr. Boyd’s primary research areas include melanoma biology, biomarker discovery for cancer prognosis and treatment response, genetic mutations in cancer progression, and the molecular pathways involved in therapeutic resistance. Her studies leverage cutting-edge techniques like liquid biopsy to non-invasively monitor treatment efficacy and predict patient outcomes.
Key Projects: She contributed to the 2015 Live-cell confocal microscope research initiative, collaborating with multidisciplinary teams to advance cellular imaging and oncology research.
Publications: Her recent work highlights advancements in circulating tumor DNA as a predictive biomarker for anti-PD1 therapies and insights into BRAF/MEK inhibitor resistance mechanisms in melanoma. These studies underscore her expertise in translating molecular findings into clinical applications.
Grants & Advising: While specific grant details are not listed, her involvement in collaborative projects indicates active participation in funded research initiatives.
Labs/Teams: She is part of the Macquarie Medical School’s oncology research group, contributing to interdisciplinary efforts in melanoma and molecular oncology research.
